Verisante receives F&S technology innovation award
Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has received the Frost & Sullivan 2014 North American Technology Innovation Leadership of the Year Award for In Vivo Cancer Detection for its skin...
View ArticleFinding the origins of cancer with Rosetta Genomics
Taking its name from the Rosetta Stone, which paved the way to decipher ancient Egyptian hieroglyphics, Rosetta Genomics (NASDAQ:ROSG) is unlocking the relevance of microRNA within the human genome to...
View Article
More Pages to Explore .....